{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T14:39:10Z","timestamp":1793716750006,"version":"4.6.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T00:00:00Z","timestamp":1628035200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T00:00:00Z","timestamp":1628035200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81970445"],"award-info":[{"award-number":["81970445"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2016FYC1300103"],"award-info":[{"award-number":["2016FYC1300103"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>H type hypertension is defined as homocysteine (Hcy)\u2009\u2265\u200910\u00a0\u03bcmol\/L in combination with primary hypertension. Studies demonstrated that the existence of hyperhomocysteine (HHcy) in hypertensive exacerbates the poor outcome of cardiocerebral incidents. This study was to investigate the current epidemic situation of H type hypertension and determine the risk factors in order to find intervention targets for H type hypertensives.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We conducted a cross-sectional study using cluster sampling design in Shanghai, China from July 2019 and April 2020. 23,652 patients with primary hypertension were enrolled in this study. Their medical information was recorded, and the level of Hcy concentrations and methylenetetrahydrofolate reductase (MTHFR) C677T polymorphisms were detected.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In total, 22,731 of 23,652 patients were recorded. The mean age was 68.9\u2009\u00b1\u20098.6\u00a0y and 43% were men. 80.0% of the enrolled patients had H type hypertension. The frequency of allele T was 40.9%, and the proportions of the CC, CT, and TT genotypes were 36.1%, 46.0%, and 17.9%, respectively. Compared with the TT genotype, the plasma Hcy concentration levels were lower in patients with the CC\/CT genotype (18.96\u2009\u00b1\u200913.48\u00a0\u03bcmol\/L vs. 13.62\u2009\u00b1\u20095.20\/14.28\u2009\u00b1\u20095.36, F\u2009=\u200975.04, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01). The risk for H type hypertension was higher in elderly people. Men had ~\u20095.55-fold odds of H type hypertension compared with women. Patients with CT genotype and TT genotype had ~\u20091.36- and ~\u20092.76-fold odds of H type hypertension compared with those with CC genotype, respectively. Smoking and diabetes were not significantly associated with H type hypertension.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The prevalence of H type hypertension in patients with primary hypertension was 80.0%, which was higher than the 75% found in prior report in China. Age, gender, and MTHFR C677T polymorphisms rather than smoking and diabetes were independently associated with H type hypertension.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12872-021-02151-x","type":"journal-article","created":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T07:02:52Z","timestamp":1628060572000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["The prevalence, relative risk factors and MTHFR C677T genotype of H type hypertension of the elderly hypertensives in Shanghai, China: a cross-section study"],"prefix":"10.1186","volume":"21","author":[{"given":"Xiao-lin","family":"Qian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-hui","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-qin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-lu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-feng","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-na","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu-cheng","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-juan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao-qiang","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-bo","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,4]]},"reference":[{"key":"2151_CR1","first-page":"111","volume":"56","author":"KS McCully","year":"1969","unstructured":"McCully KS. Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol. 1969;56:111\u201328.","journal-title":"Am J Pathol"},{"key":"2151_CR2","doi-asserted-by":"publisher","first-page":"e107498","DOI":"10.1371\/journal.pone.0107498","volume":"9","author":"C Zhong","year":"2014","unstructured":"Zhong C, Lv L, Liu C, Zhao L, Zhou M, Sun W, et al. High homocysteine and blood pressure related to poor outcome of acute ischemia stroke in Chinese population. PLoS ONE. 2014;9:e107498.","journal-title":"PLoS ONE"},{"key":"2151_CR3","first-page":"8725908","volume":"2018","author":"T Li","year":"2018","unstructured":"Li T, Zhu J, Fang Q, Duan X, Zhang M, Diao S, et al. Association of H-type hypertension with stroke severity and prognosis. Biomed Res Int. 2018;2018:8725908.","journal-title":"Biomed Res Int"},{"key":"2151_CR4","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1042\/CS20090142","volume":"118","author":"W Zhang","year":"2009","unstructured":"Zhang W, Sun K, Chen J, Liao Y, Qin Q, Ma A, et al. High plasma homocysteine levels contribute to the risk of stroke recurrence and all-cause mortality in a large prospective stroke population. Clin Sci Lond. 2009;118:187\u201394.","journal-title":"Clin Sci Lond"},{"key":"2151_CR5","first-page":"Cd006612","volume":"8","author":"AJ Mart\u00ed-Carvajal","year":"2017","unstructured":"Mart\u00ed-Carvajal AJ, Sol\u00e0 I, Lathyris D, Dayer M. Homocysteine-lowering interventions for preventing cardiovascular events. Cochrane Database Syst Rev. 2017;8:Cd006612.","journal-title":"Cochrane Database Syst Rev"},{"key":"2151_CR6","doi-asserted-by":"publisher","first-page":"358","DOI":"10.3109\/10641963.2014.972563","volume":"37","author":"M Jotoku","year":"2015","unstructured":"Jotoku M, Okura T, Miyoshi K, Irita J, Nagao T, Kukida M, et al. Carotid hemodynamics is associated with monocyte count determined by serum homocysteine level in patients with essential hypertension. Clin Exp Hypertens. 2015;37:358\u201363.","journal-title":"Clin Exp Hypertens"},{"key":"2151_CR7","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jns.2010.07.013","volume":"298","author":"A Towfighi","year":"2010","unstructured":"Towfighi A, Markovic D, Ovbiagele B. Pronounced association of elevated serum homocysteine with stroke in subgroups of individuals: a nationwide study. J Neurol Sci. 2010;298:153\u20137.","journal-title":"J Neurol Sci"},{"key":"2151_CR8","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1093\/aje\/kwf157","volume":"156","author":"U Lim","year":"2002","unstructured":"Lim U, Cassano PA. Homocysteine and blood pressure in the Third National Health and Nutrition Examination Survey, 1988\u20131994. Am J Epidemiol. 2002;156:1105\u201313.","journal-title":"Am J Epidemiol"},{"key":"2151_CR9","doi-asserted-by":"publisher","first-page":"e12626","DOI":"10.1097\/MD.0000000000012626","volume":"97","author":"J Liu","year":"2018","unstructured":"Liu J, Quan J, Li Y, Wu Y, Yang L. Blood homocysteine levels could predict major adverse cardiac events in patients with acute coronary syndrome: a STROBE-compliant observational study. Medicine. 2018;97:e12626.","journal-title":"Medicine"},{"key":"2151_CR10","doi-asserted-by":"publisher","first-page":"2766","DOI":"10.1161\/01.CIR.0000131942.77635.2D","volume":"109","author":"H Iso","year":"2004","unstructured":"Iso H, Moriyama Y, Sato S, Kitamura A, Tanigawa T, Yamagishi K, et al. Serum total homocysteine concentrations and risk of stroke and its subtypes in Japanese. Circulation. 2004;109:2766\u201372.","journal-title":"Circulation"},{"key":"2151_CR11","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1001\/jama.1995.03530190040032","volume":"274","author":"O Nyg\u00e5rd","year":"1995","unstructured":"Nyg\u00e5rd O, Vollset SE, Refsum H, Stensvold I, Tverdal A, Nordrehaug JE, et al. Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. JAMA. 1995;274:1526\u201333.","journal-title":"JAMA"},{"key":"2151_CR12","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S0021-9150(02)00105-3","volume":"164","author":"Y Moriyama","year":"2002","unstructured":"Moriyama Y, Okamura T, Kajinami K, Iso H, Inazu A, Kawashiri M, et al. Effects of serum B vitamins on elevated plasma homocysteine levels associated with the mutation of methylenetetrahydrofolate reductase gene in Japanese. Atherosclerosis. 2002;164:321\u20138.","journal-title":"Atherosclerosis"},{"key":"2151_CR13","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1093\/jn\/137.2.407","volume":"137","author":"L Hao","year":"2007","unstructured":"Hao L, Ma J, Zhu J, Stampfer MJ, Tian Y, Willett WC, et al. High prevalence of hyperhomocysteinemia in Chinese adults is associated with low folate, vitamin B-12, and vitamin B-6 status. J Nutr. 2007;137:407\u201313.","journal-title":"J Nutr"},{"key":"2151_CR14","doi-asserted-by":"publisher","first-page":"e27","DOI":"10.1111\/1755-5922.12002","volume":"31","author":"S Jiang","year":"2013","unstructured":"Jiang S, Chen Q, Venners SA, Zhong G, Hsu YH, Xing H, et al. Effect of simvastatin on plasma homocysteine levels and its modification by MTHFR C677T polymorphism in Chinese patients with primary hyperlipidemia. Cardiovasc Ther. 2013;31:e27-33.","journal-title":"Cardiovasc Ther"},{"key":"2151_CR15","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/0735-1097(95)00508-0","volume":"27","author":"EL Mayer","year":"1996","unstructured":"Mayer EL, Jacobsen DW, Robinson K. Homocysteine and coronary atherosclerosis. J Am Coll Cardiol. 1996;27:517\u201327.","journal-title":"J Am Coll Cardiol"},{"key":"2151_CR16","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1056\/NEJM199707243370403","volume":"337","author":"O Nyg\u00e5rd","year":"1997","unstructured":"Nyg\u00e5rd O, Nordrehaug JE, Refsum H, Ueland PM, Farstad M, Vollset SE. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med. 1997;337:230\u20136.","journal-title":"N Engl J Med"},{"key":"2151_CR17","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1055\/s-0038-1667141","volume":"28","author":"S Harris","year":"2019","unstructured":"Harris S, Rasyid A, Kurniawan M, Mesiano T, Hidayat R. Association of high blood homocysteine and risk of increased severity of ischemic stroke events. Int J Angiol. 2019;28:34\u20138.","journal-title":"Int J Angiol"},{"key":"2151_CR18","first-page":"976","volume":"47","author":"DY Hu","year":"2008","unstructured":"Hu DY. Xu XP [Prevention of stroke relies on valid control \u201cH\u201d type hypertension]. Zhonghua Nei Ke Za Zhi. 2008;47:976\u20137.","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"2151_CR19","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1515\/jtim-2015-0027","volume":"3","author":"J Li","year":"2015","unstructured":"Li J, Jiang S, Zhang Y, Tang G, Wang Y, Mao G, et al. H-type hypertension and risk of stroke in chinese adults: a prospective, nested case-control study. J Transl Int Med. 2015;3:171\u20138.","journal-title":"J Transl Int Med"},{"key":"2151_CR20","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.thromres.2005.04.009","volume":"117","author":"HJ Huh","year":"2006","unstructured":"Huh HJ, Chi HS, Shim EH, Jang S, Park CJ. Gene\u2013nutrition interactions in coronary artery disease: correlation between the MTHFR C677T polymorphism and folate and homocysteine status in a Korean population. Thromb Res. 2006;117:501\u20136.","journal-title":"Thromb Res"},{"key":"2151_CR21","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.gene.2012.05.029","volume":"504","author":"RA Mahfouz","year":"2012","unstructured":"Mahfouz RA, Cortas NK, Charafeddine KM, Abdul Khalik RN, Sarieddine DS, Kadi RH, et al. Correlation of methylenetetrahydrofolate reductase polymorphisms with homocysteine metabolism in healthy Lebanese adults. Gene. 2012;504:175\u201380.","journal-title":"Gene"},{"key":"2151_CR22","first-page":"137","volume":"48","author":"AH Sadewa","year":"2002","unstructured":"Sadewa AH, Sunarti Sutomo R, Hayashi C, Lee MJ, Ayaki H, et al. The C677T mutation in the methylenetetrahydrofolate reductase gene among the Indonesian Javanese population. Kobe J Med Sci. 2002;48:137\u201344.","journal-title":"Kobe J Med Sci"},{"key":"2151_CR23","doi-asserted-by":"publisher","first-page":"353","DOI":"10.2165\/00129784-200101050-00005","volume":"1","author":"K Nakai","year":"2001","unstructured":"Nakai K, Itoh C, Nakai K, Habano W, Gurwitz D. Correlation between C677T MTHFR gene polymorphism, plasma homocysteine levels and the incidence of CAD. Am J Cardiovasc Drugs. 2001;1:353\u201361.","journal-title":"Am J Cardiovasc Drugs"},{"key":"2151_CR24","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1161\/01.CIR.95.8.2032","volume":"95","author":"H Morita","year":"1997","unstructured":"Morita H, Taguchi J, Kurihara H, Kitaoka M, Kaneda H, Kurihara Y, et al. Genetic polymorphism of 5,10-methylenetetrahydrofolate reductase (MTHFR) as a risk factor for coronary artery disease. Circulation. 1997;95:2032\u20136.","journal-title":"Circulation"},{"key":"2151_CR25","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1161\/STROKEAHA.116.015324","volume":"48","author":"M Zhao","year":"2017","unstructured":"Zhao M, Wang X, He M, Qin X, Tang G, Huo Y, et al. Homocysteine and stroke risk: modifying effect of methylenetetrahydrofolate reductase C677T polymorphism and folic acid intervention. Stroke. 2017;48:1183\u201390.","journal-title":"Stroke"},{"key":"2151_CR26","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.117.032380","volume":"137","author":"Z Wang","year":"2018","unstructured":"Wang Z, Chen Z, Zhang L, Wang X, Hao G, Zhang Z, et al. Status of hypertension in China: results from the China Hypertension Survey, 2012\u20132015. Circulation. 2018;137:2344\u201356.","journal-title":"Circulation"},{"key":"2151_CR27","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1017\/S1368980010000546","volume":"13","author":"QG Qu","year":"2010","unstructured":"Qu QG, Gao JJ, Liu JM. Prevalence of hyperhomocysteinaemia in a Chinese elderly population. Public Health Nutr. 2010;13:1974\u201381.","journal-title":"Public Health Nutr"},{"key":"2151_CR28","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3390\/nu7010074","volume":"7","author":"B Yang","year":"2014","unstructured":"Yang B, Fan S, Zhi X, Wang Y, Wang Y, Zheng Q, et al. Prevalence of hyperhomocysteinemia in China: a systematic review and meta-analysis. Nutrients. 2014;7:74\u201390.","journal-title":"Nutrients"},{"key":"2151_CR29","unstructured":"Zhang Z, Fang X, Ji X, Tang Z, Wang C, Qian H, et al. [The prevalence and relative risk factors of H type hypertension in elderly patients living in Beijing.] Chin J Postgrad Med. 2018;41:443\u20138. (in Chinese)."},{"key":"2151_CR30","unstructured":"Liu H. [The investigation of hyperhomocysteinemia in patients with primary hypertension living in Daxing district of Beijing.] Chin J Rural Med Pharm. 2016;23:64\u20135. (in Chinese)"},{"key":"2151_CR31","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1093\/ajh\/hpx222","volume":"31","author":"Z Yan","year":"2018","unstructured":"Yan Z, Wang Y, Li S, Wang J, Zhang L, Tan H, et al. Hypertension control in adults with CKD in China: baseline results from the Chinese Cohort Study of Chronic Kidney Disease (C-STRIDE). Am J Hypertens. 2018;31:486\u201394.","journal-title":"Am J Hypertens"},{"key":"2151_CR32","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/sdi.12195","volume":"27","author":"T Shafi","year":"2014","unstructured":"Shafi T, Waheed S, Zager PG. Hypertension in hemodialysis patients: an opinion-based update. Semin Dial. 2014;27:146\u201353.","journal-title":"Semin Dial"},{"key":"2151_CR33","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S0272-6386(04)00813-3","volume":"44","author":"T Ninomiya","year":"2004","unstructured":"Ninomiya T, Kiyohara Y, Kubo M, Tanizaki Y, Tanaka K, Okubo K, et al. Hyperhomocysteinemia and the development of chronic kidney disease in a general population: the Hisayama study. Am J Kidney Dis. 2004;44:437\u201345.","journal-title":"Am J Kidney Dis"},{"key":"2151_CR34","first-page":"351","volume":"33","author":"Y Zhou","year":"2012","unstructured":"Zhou Y, Qi H, Zhao GM, Yang LM. Sun Q [Relationship between hyperuricemia and chronic kidney disease in Pudong New Area of Shanghai]. Zhonghua Liu Xing Bing Xue Za Zhi. 2012;33:351\u20135.","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"key":"2151_CR35","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/S0140-6736(12)60033-6","volume":"379","author":"L Zhang","year":"2012","unstructured":"Zhang L, Wang F, Wang L, Wang W, Liu B, Liu J, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet. 2012;379:815\u201322.","journal-title":"Lancet"},{"key":"2151_CR36","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1053\/euhj.1999.1522","volume":"20","author":"P Verhoef","year":"1999","unstructured":"Verhoef P, Meleady R, Daly LE, Graham IM, Robinson K, Boers GHJ. Homocysteine, vitamin status and risk of vascular disease. Effects of gender and menopausal status. Eur Heart J. 1999;20:1234\u201344.","journal-title":"Eur Heart J"},{"key":"2151_CR37","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1210\/jcem.83.2.4574","volume":"83","author":"EJ Giltay","year":"1998","unstructured":"Giltay EJ, Hoogeveen EK, Elbers JM, Gooren LJ, Asscheman H, Stehouwer CD. Effects of sex steroids on plasma total homocysteine levels: a study in transsexual males and females. J Clin Endocrinol Metab. 1998;83:550\u20133.","journal-title":"J Clin Endocrinol Metab"},{"key":"2151_CR38","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2143\/AC.61.1.2005138","volume":"61","author":"G Taskin","year":"2006","unstructured":"Taskin G, Yilmaz Sipahi E, Yildirimkaya M, Nadirler F, Halloran M, Ayoglu FN, et al. Plasma total homocysteine levels in a healthy Turkish population sample. Acta Cardiol. 2006;61:35\u201342.","journal-title":"Acta Cardiol"},{"key":"2151_CR39","doi-asserted-by":"publisher","first-page":"3630","DOI":"10.1093\/jn\/133.11.3630","volume":"133","author":"L Hao","year":"2003","unstructured":"Hao L, Ma J, Stampfer MJ, Ren A, Tian Y, Tang Y, et al. Geographical, seasonal and gender differences in folate status among Chinese adults. J Nutr. 2003;133:3630\u20135.","journal-title":"J Nutr"},{"key":"2151_CR40","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/j.1365-2362.2004.01319.x","volume":"34","author":"GT Russo","year":"2004","unstructured":"Russo GT, Di Benedetto A, Giorda C, Alessi E, Crisafulli G, Ientile R, et al. Correlates of total homocysteine plasma concentration in type 2 diabetes. Eur J Clin Invest. 2004;34:197\u2013204.","journal-title":"Eur J Clin Invest"},{"key":"2151_CR41","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.2337\/diacare.23.12.1816","volume":"23","author":"M Buysschaert","year":"2000","unstructured":"Buysschaert M, Dramais AS, Wallemacq PE, Hermans MP. Hyperhomocysteinemia in type 2 diabetes: relationship to macroangiopathy, nephropathy, and insulin resistance. Diabetes Care. 2000;23:1816\u201322.","journal-title":"Diabetes Care"},{"key":"2151_CR42","doi-asserted-by":"publisher","first-page":"420","DOI":"10.2337\/diacare.23.3.420","volume":"23","author":"A Passaro","year":"2000","unstructured":"Passaro A, D\u2019Elia K, Pareschi PL, Calzoni F, Carantoni M, Fellin R, et al. Factors influencing plasma homocysteine levels in type 2 diabetes. Diabetes Care. 2000;23:420\u20131.","journal-title":"Diabetes Care"},{"key":"2151_CR43","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s00592-009-0169-5","volume":"48","author":"GT Russo","year":"2011","unstructured":"Russo GT, Di Benedetto A, Magazz\u00f9 D, Giandalia A, Giorda CB, Ientile R, et al. Mild hyperhomocysteinemia, C677T polymorphism on methylenetetrahydrofolate reductase gene and the risk of macroangiopathy in type 2 diabetes: a prospective study. Acta Diabetol. 2011;48:95\u2013101.","journal-title":"Acta Diabetol"},{"key":"2151_CR44","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/0049-3848(96)00121-1","volume":"83","author":"PE McAndrew","year":"1996","unstructured":"McAndrew PE, Brandt JT, Pearl DK, Prior TW. The incidence of the gene for thermolabile methylene tetrahydrofolate reductase in African Americans. Thromb Res. 1996;83:195\u20138.","journal-title":"Thromb Res"},{"key":"2151_CR45","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1089\/10906570050501560","volume":"4","author":"RD Pollak","year":"2000","unstructured":"Pollak RD, Friedlander Y, Pollak A, Idelson M, Bejarano Achache I, Blumenfeld A. Ethnic differences in the frequency of the C677T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene in healthy Israeli populations. Genet Test. 2000;4:309\u201311.","journal-title":"Genet Test"},{"key":"2151_CR46","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1475-2891-11-2","volume":"11","author":"X Qin","year":"2012","unstructured":"Qin X, Li J, Cui Y, Liu Z, Zhao Z, Ge J, et al. MTHFR C677T and MTR A2756G polymorphisms and the homocysteine lowering efficacy of different doses of folic acid in hypertensive Chinese adults. Nutr J. 2012;11:2.","journal-title":"Nutr J"},{"key":"2151_CR47","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1161\/01.CIR.98.23.2520","volume":"98","author":"L Brattstr\u00f6m","year":"1998","unstructured":"Brattstr\u00f6m L, Wilcken DE, Ohrvik J, Brudin L. Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: the result of a meta-analysis. Circulation. 1998;98:2520\u20136.","journal-title":"Circulation"},{"issue":"64","key":"2151_CR48","first-page":"428","volume":"2018","author":"M Yuan","year":"1992","unstructured":"Yuan M, Wang B, Tan S. Mecobalamin and early functional outcomes of ischemic stroke patients with H-type hypertension. Rev Assoc Med Bras. 1992;2018(64):428\u201332.","journal-title":"Rev Assoc Med Bras"},{"key":"2151_CR49","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1161\/01.CIR.93.1.7","volume":"93","author":"PF Jacques","year":"1996","unstructured":"Jacques PF, Bostom AG, Williams RR, Ellison RC, Eckfeldt JH, Rosenberg IH, et al. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation. 1996;93:7\u20139.","journal-title":"Circulation"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-021-02151-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-021-02151-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-021-02151-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T08:06:16Z","timestamp":1628064376000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-021-02151-x"}},"subtitle":["Prevalence of H type hypertension"],"short-title":[],"issued":{"date-parts":[[2021,8,4]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2151"],"URL":"https:\/\/doi.org\/10.1186\/s12872-021-02151-x","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,4]]},"assertion":[{"value":"3 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocol for conduct was approved by the ethics committee of Zhongshan Hospital Fudan University. All invited participants provided written informed consents.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"376"}}